{
    "2018-12-18": [
        [
            {
                "time": "2018-03-15",
                "original_text": "The Zacks Analyst Blog Highlights: McDonald’s, AbbVie, Altria, Wells Fargo and Disney",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "McDonald’s",
                        "AbbVie",
                        "Altria",
                        "Wells Fargo",
                        "Disney"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "healthcare",
                        "finance",
                        "entertainment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-22",
                "original_text": "Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Humira",
                        "Psoriatic Arthritis",
                        "Study"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-10",
                "original_text": "Pfizer: Recent Developments and Analysts’ Recommendations",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Developments",
                        "Analysts’ Recommendations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "AbbVie (ABBV) Stock Moves -0.79%: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock Moves",
                        "-0.79%"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}